drugset / Trial / NCT00700622
Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study is to demonstrate that TI® Inhalation Powder combined with Lantus® is as effective as Humalog® combined with Lantus® on HbA1c.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-11
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 15 iu | Inhaled |
| Subject | Insulin | Protein / enzyme biologic | 30 iu | Inhaled |
| Subject | Insulin Lispro | Protein / enzyme biologic | — | — |
| Background | insulin glargine | Protein / enzyme biologic | — | Other |